Astrana Health ROE 2016-2026 | ASTH
Current and historical return on equity (ROE) values for Astrana Health (ASTH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Astrana Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.04B | $0.81B | 4.94% |
| 2026-03-31 | $0.03B | $0.79B | 3.66% |
| 2025-12-31 | $0.02B | $0.78B | 2.84% |
| 2025-09-30 | $0.01B | $0.76B | 1.19% |
| 2025-06-30 | $0.03B | $0.74B | 3.39% |
| 2025-03-31 | $0.04B | $0.72B | 4.90% |
| 2024-12-31 | $0.04B | $0.69B | 6.21% |
| 2024-09-30 | $0.06B | $0.67B | 9.30% |
| 2024-06-30 | $0.07B | $0.64B | 10.64% |
| 2024-03-31 | $0.06B | $0.61B | 10.15% |
| 2023-12-31 | $0.06B | $0.58B | 10.27% |
| 2023-09-30 | $0.04B | $0.57B | 7.78% |
| 2023-06-30 | $0.05B | $0.55B | 8.26% |
| 2023-03-31 | $0.04B | $0.52B | 8.40% |
| 2022-12-31 | $0.05B | $0.51B | 8.89% |
| 2022-09-30 | $0.06B | $0.48B | 12.00% |
| 2022-06-30 | $0.07B | $0.47B | 14.84% |
| 2022-03-31 | $0.07B | $0.45B | 15.74% |
| 2021-12-31 | $0.07B | $0.41B | 16.74% |
| 2021-09-30 | $0.07B | $0.38B | 18.35% |
| 2021-06-30 | $0.05B | $0.33B | 16.12% |
| 2021-03-31 | $0.05B | $0.28B | 16.82% |
| 2020-12-31 | $0.04B | $0.24B | 15.73% |
| 2020-09-30 | $0.04B | $0.21B | 16.93% |
| 2020-06-30 | $0.02B | $0.20B | 11.14% |
| 2020-03-31 | $0.02B | $0.19B | 9.90% |
| 2019-12-31 | $0.02B | $0.19B | 7.98% |
| 2019-09-30 | $0.01B | $0.19B | 2.70% |
| 2019-06-30 | $0.01B | $0.18B | 5.44% |
| 2019-03-31 | $0.01B | $0.18B | 4.97% |
| 2018-12-31 | $0.01B | $0.18B | 6.18% |
| 2018-09-30 | $0.04B | $0.17B | 23.63% |
| 2018-06-30 | $0.04B | $0.13B | 29.86% |
| 2018-03-31 | $0.04B | $0.08B | 44.31% |
| 2017-12-31 | $0.04B | $0.04B | 95.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |